Confidential Disclosure Agreement In Clinical Research Template for Singapore

A Confidential Disclosure Agreement In Clinical Research is a legally binding contract that protects sensitive information shared between parties involved in clinical trials and medical research studies. When you're conducting clinical research in Singapore, this agreement ensures that confidential data, including patient information, research protocols, and proprietary methodologies, remains secure while enabling essential collaboration between different stakeholders.

When do you need this document?

You need this agreement whenever multiple parties are involved in clinical research activities and must share confidential information. Research institutions entering partnerships with pharmaceutical companies require this protection when sharing study protocols and patient data. Contract Research Organizations (CROs) need these agreements when accessing proprietary research methodologies from sponsors. Healthcare facilities must have confidentiality protections in place when participating in multi-site clinical trials. Individual investigators require these agreements when collaborating with industry partners or when accessing confidential research databases. The agreement becomes essential during regulatory submissions where sensitive clinical data must be shared with multiple stakeholders while maintaining confidentiality.

Key legal considerations

Your agreement must clearly define what constitutes confidential information, including clinical trial data, patient records, research protocols, statistical analyses, and regulatory submissions. You need robust provisions for data handling that specify permitted uses, storage requirements, and access restrictions. The agreement should include specific obligations for each party, detailing how confidential information can be used, who may access it, and under what circumstances disclosure is permitted. Return or destruction clauses are critical, requiring parties to return or securely destroy confidential information when the research concludes. You must also include provisions for breach remedies, as unauthorized disclosure of clinical research data can result in significant regulatory and commercial consequences. Consider including specific carve-outs for information that becomes publicly available or was independently developed.

Legal requirements in Singapore

Your agreement must comply with the Personal Data Protection Act 2012 (PDPA), which governs the collection, use, and disclosure of personal data in Singapore. You need to ensure compliance with the Human Biomedical Research Act 2015, which regulates the conduct of human biomedical research and mandates specific confidentiality protections for research participants. The Health Products Act and associated Clinical Trials Regulations impose additional requirements for maintaining confidentiality of clinical trial data and regulatory submissions. Your agreement should reference the Singapore Guideline for Good Clinical Practice, which provides specific standards for data integrity and confidentiality in clinical research. You must also consider the Medicines Act requirements when the research involves pharmaceutical products, ensuring that confidential information related to drug development and clinical trials receives appropriate protection under Singapore law.